Conducting clinical trials for medical devices requires careful management of participant confidentiality agreements. This Medical Device Testing Participant NDA template helps research organizations, medical device manufacturers, and clinical trial coordinators establish clear confidentiality expectations with study participants while protecting proprietary device information and trial data.
Unlike standard non-disclosure agreements, medical device testing requires balancing participant safety rights with the protection of proprietary technology and unpublished research data. Participants need clear guidance on what information must remain confidential, how adverse events should be reported, and what compensation they'll receive—all while ensuring they understand their rights and obligations.
This form template addresses the unique requirements of medical device clinical trials by combining confidentiality provisions with adverse event reporting procedures and transparent compensation details, creating a comprehensive agreement that protects both the study sponsor and participant interests.
This template is designed for:
The form captures essential information including participant demographics, study understanding confirmation, specific confidentiality obligations regarding device specifications and performance data, adverse event reporting procedures, compensation details, and digital signature capture for legally binding acknowledgment.
Conditional logic ensures participants receive appropriate information based on their study role and compensation structure, while required fields guarantee no critical documentation is missed before enrollment proceeds.
Once a participant submits this NDA, Stepper can automate your entire enrollment workflow: send the signed agreement to your trial management system, create participant records in your CRM or database, schedule orientation appointments, trigger follow-up emails with study protocols, and notify the principal investigator and study coordinator team. You can also use Papersign to collect additional signatures from legal guardians, co-investigators, or compliance officers if your protocol requires multiple sign-offs.
With Paperform's SOC 2 Type II compliance and secure data handling, you can trust that sensitive participant information and proprietary device data remain protected throughout the trial lifecycle. Built-in calculations handle compensation automatically, while professional design ensures participants have a clear, trustworthy experience from first contact.
A comprehensive confidentiality agreement for clinical research participants that covers study data protection, privacy rights, compensation details, and IRB compliance requirements.
A comprehensive consent form for clinical research participants covering data collection, anonymization, storage, and publication rights with clear explanations of privacy protections.
A comprehensive form for requesting clinical research protocol documentation, IRB approvals, informed consent versions, adverse event reports, and audit findings for regulatory compliance and review purposes.
A comprehensive informed consent form for clinical trial participants, documenting voluntary agreement, study risks, benefits, privacy protections, and IRB approval in a legally binding format.
A confidential reporting form for clinical trial protocol deviations with IRB notification and participant safety review pathways.
Request modifications to clinical trial protocols with IRB submission requirements, patient safety assessment, regulatory compliance checklist, and principal investigator approval workflow.
A comprehensive serious adverse event (SAE) reporting form for clinical trials, capturing subject enrollment details, investigator assessment, causality determination, IRB notification requirements, and FDA safety reporting compliance.
Comprehensive medical records release form for patients enrolling in medical device clinical trials, including baseline health assessments, device implantation details, follow-up schedules, and adverse event documentation.
A comprehensive data use agreement for medical research participants that covers de-identification requirements, data sharing permissions, and publication rights.
A comprehensive form for submitting clinical trial applications to Norwegian ethics committees, including participant consent documentation, adverse event reporting protocols, and regulatory compliance requirements.
Comprehensive non-disclosure agreement for pharmaceutical research protecting clinical trial data, drug formulations, and ensuring FDA compliance acknowledgment for researchers, partners, and vendors.
A comprehensive non-disclosure agreement for participants in regenerative medicine and stem cell treatment programs, protecting experimental therapy details, treatment outcomes, and research data while facilitating secure payment processing.